Stock REGN REGENERON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Real-time Estimate Cboe BZX
Other stock markets
 03:34:31 2024-06-05 pm EDT 		5-day change 1st Jan Change
1,010 USD +1.68% Intraday chart for Regeneron Pharmaceuticals, Inc. +4.26% +14.73%
02:30pm Transcript : Regeneron Pharmaceuticals, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 08:30 AM
Jun. 04 RBC Adjusts Price Target on Regeneron Pharmaceuticals to $1,200 From $1,185 MT

Chart calendar Regeneron Pharmaceuticals, Inc.

f.gNCH6iiefm8IcEmr9LxkFcX-Ckzd4XcT_Y2NP96VBhM.2JXXoRHdGllxIAH5h9YUfa2XZH2X1yJir_6-b7nHViPSvrSfXNsQHmoyfQ~5b309ed9eb32557487abbf22809f63ac

Upcoming events on Regeneron Pharmaceuticals, Inc.

2024-06-11 08:00 am Goldman Sachs Global Healthcare Conference
2024-06-14 10:30 am Annual General Meeting
2024-07-31 Q2 2024 Earnings Release (Projected)
2024-10-30 Q3 2024 Earnings Release (Projected)
2025-01-30 Q4 2024 Earnings Release (Projected)
2025-04-30 Q1 2025 Earnings Release (Projected)

Past events on Regeneron Pharmaceuticals, Inc.

Today 08:30 am Jefferies Global Healthcare Conference
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract No: TPS8663
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract No: TPS8660
2024-06-03 12:30 pm American Society of Clinical Oncology Meeting - Abstract No :2503
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No: 5522
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No: 7076
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No: 7093
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No: TPS5632
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No: 7094
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No: 7560
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No; 7096
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No: 7086
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No: 7561
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No: 7099
2024-06-02 10:00 am American Society of Clinical Oncology Meeting - Abstract No: 6038
2024-06-02 10:00 am American Society of Clinical Oncology Meeting - Abstract No : 6100
2024-06-01 02:30 pm American Society of Clinical Oncology Meeting - Abstract No: TPS9611
2024-06-01 10:00 am American Society of Clinical Oncology Meeting - Abstract No : 2650
2024-05-14 09:00 am RBC Capital Markets Global Healthcare Conference
2024-05-11 08:15 am American Society of Gene & Cell Therapy Meeting - Abstract No -353

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		7 863
7 816
0.61%		8 497
8 494
0.04%		16 072
15 679
2.51%		12 173
11 850
2.73%		13 117
12 921
1.52%
13 822

EBITDA
Million USD		Released
Forecast
Spread 		3 420
3 610
-5.28%		4 245
4 158
2.09%		9 835
9 709
1.29%		6 060
6 161
-1.63%		5 547
5 452
1.74%
5 532

EBIT
Million USD		Released
Forecast
Spread 		2 210
2 285
-3.29%		3 577
3 485
2.64%		8 947
9 034
-0.96%		5 719
5 561
2.84%		5 126
5 082
0.87%
5 087

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		2 429
2 308
5.26%		3 810
3 582
6.39%		9 326
9 442
-1.23%		4 859
4 812
0.97%		4 199
4 276
-1.8%
4 115

Net income
Million USD		Released
Forecast
Spread 		2 116
1 998
5.87%		3 513
3 160
11.18%		8 075
8 014
0.77%		4 338
4 166
4.14%		3 954
3 808
3.83%
3 960

EPS
USD		Released
Forecast
Spread 		18,5
17,6
4.67%		30,5
28,0
8.96%		72,0
71,1
1.17%		38,2
36,3
5.31%		34,8
33,9
2.62%
33,8

Announcement Date06/02/2005/02/2104/02/2203/02/2302/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		2 965
2 690
10.22%		2 857
2 797
2.14%		2 936
2 870
2.29%		3 414
3 113
9.7%		3 162
2 998
5.48%		3 158
3 025
4.41%		3 363
3 222
4.36%		3 434
3 287
4.49%		3 145
3 221
-2.35%
3 372


3 553


3 723


3 566


3 617

EBITDA
Million USD		Released
Forecast
Spread 		1 558
1 376
13.24%		1 344
1 220
10.17%		1 488
1 344
10.67%		1 637
1 336
22.54%		1 315
1 219
7.84%		1 351
1 175
14.98%		1 488
1 288
15.47%		1 395
1 500
-7.01%		1 142
1 195
-4.43%
1 311


1 496


1 613


1 193


1 285

EBIT
Million USD		Released
Forecast
Spread 		1 483
1 273
16.56%		1 285
1 124
14.37%		1 413
1 266
11.62%		1 537
1 344
14.33%		1 215
1 203
1.01%		1 248
1 216
2.63%		1 382
1 272
8.7%		1 282
1 248
2.74%		1 028
1 168
-12.04%
1 208


1 346


1 411


1 312


1 369

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		1 061
1 185
-10.43%		963
1 116
-13.71%		1 510
984
53.36%		1 325
1 154
14.81%		858
1 009
-14.97%		1 083
1 041
4%		1 111
1 154
-3.72%		1 148
1 308
-12.24%		701
1 212
-42.18%
1 111


1 171


1 196


1 233


1 339

Net income
Million USD		Released
Forecast
Spread 		974
1 038
-6.2%		852
794
7.38%		1 316
845
55.67%		1 197
1 060
12.94%		818
876
-6.69%		968
885
9.42%		1 008
1 071
-5.9%		1 160
1 025
13.08%		722
886
-18.54%
1 035


1 145


1 169


1 109


1 155

EPS
USD		Released
Forecast
Spread 		8,61
8,77
-1.86%		7,47
7,38
1.29%		11,7
7,93
47.05%		10,5
9,23
13.73%		7,17
7,96
-9.92%		8,50
7,93
7.12%		8,89
9,04
-1.62%		10,2
9,21
10.69%		6,27
7,89
-20.52%
8,79


9,64


9,99


9,80


10,2

Announcement Date04/05/2203/08/2203/11/2203/02/2304/05/2303/08/2302/11/2302/02/2402/05/24-----

Upcoming sector events for Regeneron Pharmaceuticals, Inc.

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Regeneron Pharmaceuticals, Inc.

2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 08:00 am IMMUNOME, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. REGN Stock
  4. Calendar Regeneron Pharmaceuticals, Inc.